2017 Gary Andrews International Fellow

Professor Sube Banerjee
Professor of Dementia and Deputy Dean, Brighton and Sussex Medical School

Sube Banerjee is Professor of Dementia and Deputy Dean at Brighton and Sussex Medical School, directing its Centre for Dementia Studies. Clinically he works as an old age psychiatrist. He served as the UK Department of Health’s senior professional advisor on dementia leading the development of its National Dementia Strategy. He is active in health system development and works with industry and governments on health systems, policy and strategies to improve health for older adults with complex needs and those with dementia. An applied health researcher, he focusses on quality of life in dementia, evaluation of new treatments and services, and the interface between policy, research and practice. He has been awarded national and international awards for work in policy and research in dementia.


Sube’s research focuses on quality of life and quality of care in dementia. This involves first identifying/understanding the problems faced by those with dementia and their carers; second formulating effective, generalisable ways of addressing the problems identified; third evaluating the impact of these interventions; and finally disseminating the data and lessons derived, enabling policy change so they can be hardwired into clinical provision.

Quality of life in dementia

The experience of people with dementia and their carers is more than the sum of cognitive and behavioural measures. New treatments for dementia demand sound methodologies with which to measure overall response to treatments. Sube has been the PI on programmes of work to develop DEMQOL, a disease-specific quality of life measure for dementia. Research includes:

  • Development of a utility and monetary weighted instrument DEMQOL-U
  • Cross national studies of the natural history of quality of life in dementia
  • Further studies of the responsiveness of DEMQOL
  • Investigation of adaptation and response shift in dementia.
  • Studies of the impact of clinical service provision on quality of life in dementia
  • Development of C-DEMQOL an instrument to measure the quality of life of carers of people with dementia

Find out more about DEMQOL


Quality of care in dementia

  • Work on how we provide services for older people with mental disorder and how can we improve them includes:
  • MODEM with LSE generating comprehensive clinico-economic model for dementia including life quality outcomes.
  • HTA-SADD Trial of antidepressants for depression in dementia (CI) – clinical and cost effectiveness data published.
  • HTA-SMBAD Trial of mirtazapine and carbamazepine for agitation and aggression in dementia (CI)
  • Investigation of memory services and the process of diagnosis.
  • Development and evaluation of integrative strategies to address the “empty centre” of dementia care after diagnosis but before transition into institutional care
  • Quality of death, end of life care and advanced directives in dementia.
  • Memory services for people with HIV


Click here for more information on the Conferenc